Anchiano slips after NASDAQ offering

Anchiano Therapeutics Ltd. (Tel Aviv:ANCN; NASDAQ:ANCN) slipped $0.70 to $10.80 on NASDAQ on Tuesday after raising $30.5 million in a listing of ADSs.

The gene therapy company priced 2.6 million ADSs at $11.50, giving it a valuation of $78.5 million. Anchiano had hoped to sell 2.4 million ADSs, each of which is worth five ordinary shares. In Tel Aviv, its shares sank NIS2.05 (20%) to NIS8.22 on Tuesday...